- 期刊
- OpenAccess
抗嗜中性白血球細胞質抗體相關血管炎之中華民國風濕病醫學會診斷與治療建議
Taiwan Rheumatology Association recommendations for the diagnosis and management of anti-neutrophil cytoplasmic antibody-associated vasculitis
摘要
嗜中性白血球細胞質抗體相關血管炎（anti-neutrophil cytoplasmic antibodyassociatedvasculitides, AAVs）在台灣屬於少見的疾病。臨床的初始症候表徵相當多樣化，因此診斷不易；病程反覆且可能涉及多重器官系統，故治療上常需跨專科的合作，須考慮長期治療過程中如何嚴格控制疾病，且兼顧避免免疫抑制治療之副作用與併發症。因此本診斷與治療建議之目的在提供簡要的診斷、治療與病情追蹤建議，以提供臨床醫師在照顧AAV病患時之參考，成為持續改進AAV病人預後之基礎。
關鍵字
嗜中性白血球細胞質抗體相關血管炎並列摘要
Anti-neutrophil cytoplasmic antibody-associated vasculitides (AAVs) are uncommon in Taiwan. AAVs are hard to be diagnosed due to variable initial clinical presentations. The disease courses are highly diverse and involve multiple organ systems; therefore treatment of AAV usually requires multidiscipline cooperation. Furthermore, treatment should be balanced between tight control of the diseases and minimization of complication caused by repeated and prolonged immunosuppressive therapies. The recommendations intend to provide concise diagnosis, treatment and follow-up suggestions as a reference for caring AAV patients, herein establishing a basis for continuous improvement of AAV prognosis.
延伸閱讀
- 陳怡行、簡榮南、黃怡翔、陳得源、藍忠亮、呂聆音、謝祖怡、魏正宗、蔡嘉哲（2012）。2012年風濕病醫學會免疫風濕病患接受生物製劑治療B型肝炎篩檢與防治共識建議。Formosan Journal of Rheumatology，26(1&2)，1-7。https://doi.org/10.6313/FJR.2012.26(1-2).01
- 李宗翰、何揚（2022）。抗嗜中性白血球細胞質抗體血管炎（Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, AAV）之最新治療。腎臟與透析，34(4)，183-187。https://doi.org/10.6340/KD.202212_34(4).0006
- Lu, C. H., Shen, C. Y., Wu, C. H., & Yu, C. L. (2013). 抗嗜中性球細胞質抗體相關血管炎患者之臨床表現與治療反應：單一醫學中心之回顧性研究. Formosan Journal of Rheumatology, 27(2), 27-36. https://doi.org/10.6313/FJR.2013.27(02).02
- 李世瑜、王宏斌、陳宗賢、洪培豪、洪冠予（2020）。抗嗜中性白血球相關之血管炎。內科學誌，31(2)，91-105。https://doi.org/10.6314/JIMT.202004_31(2).04
- Huang, C. N., Hsu, T. C., Chou, H. H., & Tsay, G. J. (2004). Prevalence of Perinuclear Antineutrophil Cytoplasmic Antibody in Patients with Graves' Disease Treated with Propylthiouracil or Methimazole in Taiwan. Journal of the Formosan Medical Association, 103(4), 274-279. https://doi.org/10.29828/JFMA.200404.0004